Related Experiment Video
Updated: Apr 10, 2026
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
From Neoantigens to Nanocarriers: Modern Methods and Modalities in Using Peptides for Cancer Vaccination
Aleah Harris Treiterer1, Blaise Robinson1, Sean Huggins2
1Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, Ohio 43210, United States.
Abstract:
The success of cancer vaccination depends on the ability of therapeutics to sustain prolonged immune activation, leading to the destruction of tumor cells. However, only a few therapeutic cancer vaccines have been FDA-approved due to challenges in targeting and eliciting a sufficiently strong immune response. Peptides have emerged as promising drugs owing to their ability to interact with cell-surface receptors and their low manufacturing cost. Despite the peptides' positive characteristics, additional research is needed to develop more effective methods for using peptides to stimulate the immune system for a sustained period to induce tumor cell regression. This review focuses on recent work in peptide-based vaccine design and development, aiming to determine the optimal formulation of peptide vaccines by identifying and isolating neoantigens for tumor targeting, thereby delivering peptide antigens to specific locations. The expansion of the current landscape of cancer treatments, including peptide vaccines and combination therapies, is revolutionizing the possibilities for patient care and treatment.
Insights
Peptide cancer vaccines show promise for sustained immune activation against tumors. Optimizing peptide vaccine design by targeting neoantigens is key to improving patient treatment outcomes.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Cancer vaccines require sustained immune activation for tumor cell destruction.
- Few therapeutic cancer vaccines are FDA-approved due to targeting and immune response challenges.
- Peptides offer advantages like receptor interaction and low manufacturing cost for cancer therapy.
Purpose of the Study:
- To review recent advancements in peptide-based vaccine design for cancer.
- To explore optimal peptide vaccine formulations for sustained immune stimulation.
- To identify neoantigens for targeted tumor delivery of peptide antigens.
Main Methods:
- Review of current literature on peptide vaccine design and development.
- Analysis of strategies for neoantigen identification and isolation.
- Examination of methods for targeted delivery of peptide antigens.
Main Results:
- Peptides are promising for cancer vaccination due to their characteristics.
- Targeting specific neoantigens and optimizing delivery enhances vaccine efficacy.
- Further research is needed to refine peptide-based therapeutic strategies.
Conclusions:
- Peptide vaccines represent a growing area in cancer treatment.
- Optimized peptide vaccine design, including neoantigen targeting, can improve tumor regression.
- Peptide vaccines, especially in combination therapies, are revolutionizing cancer care possibilities.
More Related Videos
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
01:51Vaccinations
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...